BE903610A - Dispositifs contenant des implants anabolisants a liberation prolongee - Google Patents

Dispositifs contenant des implants anabolisants a liberation prolongee

Info

Publication number
BE903610A
BE903610A BE1/011375A BE1011375A BE903610A BE 903610 A BE903610 A BE 903610A BE 1/011375 A BE1/011375 A BE 1/011375A BE 1011375 A BE1011375 A BE 1011375A BE 903610 A BE903610 A BE 903610A
Authority
BE
Belgium
Prior art keywords
implants
sustained release
devices containing
anabolizing
containing sustained
Prior art date
Application number
BE1/011375A
Other languages
English (en)
Original Assignee
Ct De Rech S Biolog Virbac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct De Rech S Biolog Virbac filed Critical Ct De Rech S Biolog Virbac
Publication of BE903610A publication Critical patent/BE903610A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Des dispositifs contenant des implants anabolisants à libération prolongée, sont constitués, d'une matrice solide, à base de polymères insolubles hydrophobes associés à des esters de glycérol, de substances dites de charge et d'une ou plusieurs substances actives. Application : Utilisation comme facteur de croissance hormonal chez les bovidés.
BE1/011375A 1984-11-22 1985-11-08 Dispositifs contenant des implants anabolisants a liberation prolongee BE903610A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8418230A FR2573307B1 (fr) 1984-11-22 1984-11-22 Implants anabolisants a liberation prolongee

Publications (1)

Publication Number Publication Date
BE903610A true BE903610A (fr) 1986-05-09

Family

ID=9310081

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011375A BE903610A (fr) 1984-11-22 1985-11-08 Dispositifs contenant des implants anabolisants a liberation prolongee

Country Status (9)

Country Link
AU (1) AU585280B2 (fr)
BE (1) BE903610A (fr)
DE (1) DE3539408A1 (fr)
FR (1) FR2573307B1 (fr)
GB (1) GB2167662B (fr)
IT (1) IT1188195B (fr)
NL (1) NL8503227A (fr)
NZ (1) NZ214179A (fr)
ZA (1) ZA858486B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU573783B2 (en) * 1984-01-31 1988-06-23 International Foundation For Biochemical Endocrinology Method for promoting growth and improved meat quality with female steroidal hormones
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
US5114719A (en) * 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
US4883666A (en) * 1987-04-29 1989-11-28 Massachusetts Institute Of Technology Controlled drug delivery system for treatment of neural disorders
US5601835A (en) * 1987-04-29 1997-02-11 Massachusetts Institute Of Technology Polymeric device for controlled drug delivery to the CNS
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
US5035891A (en) * 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
US6022554A (en) * 1997-12-15 2000-02-08 American Home Products Corporation Polymeric microporous film coated subcutaneous implant
CN1243543C (zh) * 1998-07-20 2006-03-01 派普泰克有限公司 生物植入物配方
US8052982B2 (en) 1998-07-20 2011-11-08 Peptech Animal Health Pty Limited Bioimplant formulation comprising lecithin and stearin
US7767708B2 (en) 1998-11-04 2010-08-03 Schering-Plough Animal Health Corp. Growth stimulant compositions
WO2000025743A2 (fr) * 1998-11-04 2000-05-11 Schering Corporation Compositions ameliorees stimulant la croissance
US6498153B1 (en) 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
CN1220491C (zh) 1999-06-11 2005-09-28 沃特森药物公司 非口服雄激素类固醇用于制备改善性激素结合球蛋白水平升高的药物
WO2001043748A2 (fr) * 1999-12-16 2001-06-21 Pharmacia & Upjohn Company Composition d'implant contenant de l'acetate de melengestrol et de l'acetate de trenbolone
BR0207052A (pt) 2002-10-15 2004-08-10 Natura Cosmeticos Sa Composição cosmética sólida
US20100144687A1 (en) 2008-12-05 2010-06-10 Glaser Rebecca L Pharmaceutical compositions containing testosterone and an aromatase inhibitor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB215137A (en) * 1923-02-23 1924-05-08 Frank Leslie Gridner Improvements in and relating to adjustable chairs
GB1021924A (en) * 1962-06-22 1966-03-09 Smith Kline French Lab Improvements in or relating to method of preparing sustained release tablets
US3920806A (en) * 1973-05-04 1975-11-18 Merck & Co Inc Growth promoting subcutaneous compositions
FR2239988A1 (en) * 1973-08-08 1975-03-07 Aries Robert Animal hormone implants - comprising a mixt. of hormone and fatty acid ester of hormone
US3978203A (en) * 1974-07-12 1976-08-31 Dynatech Corporation Sustained release of pharmaceuticals from polyester matrices
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
US4333919A (en) * 1979-09-12 1982-06-08 Eli Lilly And Company Growth promotant controlled release formulations and method of treatment
US4331652A (en) * 1979-09-12 1982-05-25 Eli Lilly And Company Controlled release parasitic formulations and method

Also Published As

Publication number Publication date
AU4998285A (en) 1986-05-29
IT8522829A0 (it) 1985-11-14
NZ214179A (en) 1989-06-28
IT1188195B (it) 1988-01-07
AU585280B2 (en) 1989-06-15
ZA858486B (en) 1986-06-25
FR2573307A1 (fr) 1986-05-23
GB2167662B (en) 1988-11-30
NL8503227A (nl) 1986-06-16
FR2573307B1 (fr) 1988-06-10
GB2167662A (en) 1986-06-04
DE3539408A1 (de) 1986-06-05
GB8527915D0 (en) 1985-12-18

Similar Documents

Publication Publication Date Title
BE903610A (fr) Dispositifs contenant des implants anabolisants a liberation prolongee
UA29563C2 (uk) Мікрокапсула для тривалого вивільнення фізіологічно активного пептиду
IL93360A (en) Bactericidal/permeability increasing protein or biologically active analogs thereof and pharmaceutical compositions containing them
AU3065989A (en) Polypeptide compounds having growth hormone releasing activity
MY101593A (en) Sustained release preparation.
EP0973507A4 (fr) Forme galenique presentant des proprietes de dispersion rapide, ses procedes d'utilisation et son procede de preparation
ATE242633T1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
BR9610790A (pt) Formulações de gel contendo fatores de crescimento
DE69634670D1 (de) Aktives anodenmaterial und nichtwässrige sekundärbatterie
IT1307829B1 (it) Protesi dentale con mezzi per il rilascio di farmaci o fattorispecifici atti ad impedire l'insorgenza di infezioni e/o promuovere
IT1208208B (it) Copolimeri solubili e biodegradabili per legare sostanze biologicamente attive.
DE69637961D1 (de) Verabreichung von biologisch aktiven polypeptiden
UA66417C2 (en) Recombinant adenovirus affecting canines, pharmaceutical composition
GR3032673T3 (en) Use of an effective quantitiy of active substances for the treatment of mixed skin.
TR199901250T2 (xx) Tedavi ama�l� ajanlar.
IL125088A0 (en) Modulation of TH1/TH2 cytokine expression
RU96116802A (ru) Перевязочный материал
TR199902730T2 (xx) Glikrizikasit ve antiviral etkinlik kazand�r�lm�� en az�ndan bir proteini i�eren farmas�tik antiviral bile�im.
TR199701520T1 (xx) Ac�n�n iyile�tirilmesi i�in analjesik bile�ikleri �reten h�cre soyu.
DK0613368T3 (da) Hudregenererende kosmetisk sammensætning
TR200000249T2 (tr) Bir etki maddesinin deri üzerinden bir organizmaya geçirilmesi ve deri üzerine tatbik işlemine dair transdermal terapötik sistem (TTS)
FR2569987B1 (fr) Dispositif implantable autonome et son utilisation pour l'administration de substances actives dans le corps humain
BR9912566A (pt) Micropartìculas preparadas a partir de copolìmeros de cicloolefinas e sua aplicação para a liberação controlada de substâncias ativas
ATE206911T1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
MY106238A (en) Solid silicone-based agricultural compositions with biological action